Insiders · Profile

Vogt Frederick G

Interim CEO & General Counsel at IOVANCE BIOTHERAPEUTICS. Filing since 1 Jun 2022. CIK 0001719678

Company
Date
Role
Action
Shares
Amount
Of holding
14 May 2025
Interim CEO & General Counsel
Bought
25,000
$42.25K
7.2%
28 Nov 2022
Interim CEO & General Counsel
Bought
1,000
$5.98K
100%
1 Jun 2022
Interim CEO & General Counsel
Bought
1,000
$6.44K
opened
3 decisions on file.